Companies in the Genetic engineering industry

Ginkgo Bioworks is a synthetic biology and biotechnology company using machine learning techniques and lab automation to engineer microorganisms as a service.

A genetic medicine company that build data platforms using synthetic biology, artificial intelligence and genetic medicine for the development of medical therapies.

Caribou Biosciences is a Berkeley, California—based private biopharmaceutical company founded in 2011 by Jennifer Doudna and Rachel Haurwitz.

Indee Labs focuses on the development of microfluidic vortex shedding for rapidly and efficiently transfecting human primary immune cells with negligible perturbation. The team is focused on developing its core technology for short turnaround chimeric antigen receptor T cell (CAR-T) development and manufacturing.

Intellia Therapeutics is a biotechnology company founded in 2014, based in Cambridge, MA that develops biopharmaceuticals using CRISPR-Cas9 gene editing technology.

A biopharmaceutical company focused on discovery and development of small-molecule drugs to treat genetic and rare diseases.

Amicus Therapuetics is a biotechnology company developing therapies to cure rare diseases.

A biopharmaceutical and gene editing company founded in 2013. CRISPR Therapeutics AG is based in Zug, Switzerland and CRISPR Therapeutics, Inc. is the U.S. subsidiary with R&D operations in Cambridge, Massachusetts and business offices in London, U.K.

Precision BioSciences is a biotechnology developing a gene editing platform for the creation of cell therapies, gene therapies, and agricultural products.

A biotechnology that specializes in genome editing, gene therapy, cell therapy and gene regulation.

A biotechnology company founded in 2015 which operates as a subsidiary of Gilead Sciences and Kite Pharma. The company developed a platform for custom cell engineering called synNotch to be used for anticancer therapies. Their system can also be used to develop cell-based therapies for autoimmune and degenerative disorders.

A synthetic biology company using CRISPR to develop a portfolio of genetic medicines.

Sarepta Therapeutics is a biopharmaceutical company founded by Marwan Fawaz in 1980 and headquartered in Cambridge, Massachusetts developing precision genetic medicines for the treatment of rare neuromuscular diseases.

Poseida Therapeutics develops targeted cell therapy founded in 2014 by Eric Ostertag.

Voyager Therapeutics is a biotechnology company founded in 2014 that is headquartered in Cambridge, Massachusetts developing gene therapies to treat neurological disorders.

Silicon Valley-based genetic engineering startup.

Editas Medicine is a genome editing company founded in 2013 that is using CRISPR technology to treat patients with genetically defined diseases.

A company developing gene therapies for the treatment of genetic diseases and cancer.

CSL Behring is a biotechnology company developing biotherapies for the treatment of life-threatening medical conditions.

Nextbiotics is a biotechnology and synthetic biology company that leverages synthetic biology tools and bacteriophage technology to provide solutions to the antibiotic resistance crisis.

Adverum is a gene therapy company committed to discovering and developing novel medicines to patients living with rare diseases and diseases of the eye.

Catalent develops and manufactures drugs, protein-based biologics, cell and gene therapies, and consumer health products.

DNA synthesis company using enzymatic DNA synthesis based in San Francisco.

SmartPharm Therapeutics is a Cambridge, MA-based gene therapy company applying the next generation of non-viral DNA and RNA technologies to treat serious human diseases.

Integrated DNA Technologies is a Coralville, Iowa-based company founded in 1987.